	Serum small extracellular vesicle-associated snoRNA panel adds diagnostic value to CEA and CYFRA21-1 for non-small cell lung cancer: an exploratory single-center study. Front Oncol Wang L, Wang M, Zhang Q, Li X, Zhang Z, Wang K. PMID: 42798416 [PubMed - as supplied by publisher]
	NeuroTrustNet: a cost-effective multimodal ensemble framework for brain tumor classification under cross-dataset variability. Front Artif Intell Aziz FI, Koo I, Erdenebold T, Hossain JA, Fagerstrøm A, Ghose D. PMID: 42798415 [PubMed - as supplied by publisher]
	The effects of combined aerobic and resistance exercise on metabolic blood biomarkers and quality of life in patients with breast cancer: a systematic review meta-analysis. Front Oncol Ahmad MI, Raza A, Bao J, Chen X, Li Y, Li Y, Lu Y. PMID: 42798392 [PubMed - as supplied by publisher]
	Metaplastic breast cancer: a clinicopathological analysis of nine cases highlighting diagnostic challenges and aggressive behavior. Front Oncol Shao Y, Kan B, Li Y, Zhou Q, Yan G, Chen J. PMID: 42798330 [PubMed - in process]
	MRI-based radiomics for noninvasive prediction of GPC3 expression in hepatocellular carcinoma: a systematic review and meta-analysis. Front Oncol Gao R, Li X. PMID: 42798324 [PubMed - in process]
	Plasma exosomal lncRNA SLC16A1-AS1 as an early diagnostic biomarker for renal cell carcinoma. Front Oncol Sun Y, Li Z, Ren C, Wang D, Zhu X. PMID: 42798305 [PubMed - in process]
	Trial design drives outcomes: harmonising efficacy across BCG-unresponsive bladder carcinoma inÂ situ trials. BJU Int Robesti D, Kamat AM, Ploussard G, Contieri R, Fallara G, Briganti A, Montorsi F, van der Heijden AG, Malavaud B, Pohar K, Shore N, Dinney CPN, Martini A. PMID: 42798234 [PubMed - as supplied by publisher]
	The role of fibronectin in the tumor microenvironment - implications for immunotherapy. Cell Cycle Kasprzak A, Wasilewski A, Skowron K, Sowa Z, Biela K, Fendor M, Pupek M. PMID: 42798197 [PubMed - in process]
	Systemic inflammation and prognosis in patients with RAS/BRAF wild-type metastatic colorectal cancer receiving anti-EGFR therapy: A real-world cohort study. Colorectal Dis Appleyard JW, Elliott F, Sapanara NL, Zhang L, Kurkure U, Seligmann JF, West NP, Shanmugam K, Quirke P, Williams CJM, N6 Collaboration. PMID: 42798176 [PubMed - in process]
	Oncology nurse navigator core competencies and patient satisfaction: A cross-sectional correlational study at an Egyptian cancer center. Medicine (Baltimore) Bassyouny HAA, Ismail HA, Elmoaty AEEA, Aly MA, Ibrahim RK, Hendy A, Almegewly W, Hussien RM, Elhadary SMM, Kotp MH. PMID: 42798116 [PubMed - in process]
	Lung cancer and altered brain structure: A causal inference based on MR. Medicine (Baltimore) Yuan Z, Xu Z, Lv S, Dong Y, Chen A, Wang W, Cheng J. PMID: 42798054 [PubMed - in process]
	Prediction of axillary lymph node metastasis in breast cancer using preoperative CT Hounsfield units: A retrospective study. Medicine (Baltimore) Koizumi A, Sugimoto H, Yamazaki K, Nankaku A, Takashima J, Fujimoto D, Miura F, Kobayashi H. PMID: 42798050 [PubMed - in process]
	Tumor-Specific Classification of Canine Cutaneous and Subcutaneous Tumors Using Heat-Diffusion Imaging and Artificial Intelligence. Vet Sci Dank G, Buber T, Levy-Hirsh L, Kent MS, Greenberg U, Harpaz Y, Hanael E. PMID: 42797966 [PubMed - in process]
	Systemic Transcriptional Responses to Clinical Vaccine Formulations and Live-Attenuated Vaccination: Comparative Kinetics and Hypotheses for Therapeutic Cancer Vaccine Monitoring. Vaccines (Basel) Goldman CK. PMID: 42797613 [PubMed - in process]
	From Universal Aspiration to Precision Immunization: A Hypothesis Framework for Antigen-Defined, HLA-Restricted Cancer Vaccines. Vaccines (Basel) Niazi SK. PMID: 42797572 [PubMed - in process]
	Engineering Functional Biomaterials for Targeted and Localized Cancer Drug Delivery: A Structure-Property-Performance Design Perspective. Pharmaceuticals (Basel) Etinosa P, Waidi YO, Osafo S, Danyuo Y, Eluu S, Ezeala C. PMID: 42797543 [PubMed - in process]
	Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review. Pharmaceuticals (Basel) Kim SD, Kim KR, Kim DH, Yeo T, Choi MJ, Park SJ, Yoo HS. PMID: 42797537 [PubMed - in process]
	Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer. Pharmaceuticals (Basel) Aguilera-Pineda T, Kumar S, Ghosal G, Natarajan A, Karpf AR. PMID: 42797522 [PubMed]
	Gold Nanostars as Multifunctional Platforms in Cancer Imaging and Therapy: Toward Radiotheranostic Applications. Pharmaceuticals (Basel) Basirinia G, Ali M, Comelli A, Arif A, Alongi P, Di Raimondo D, Tuttolomondo A, Benfante V. PMID: 42797521 [PubMed - in process]
	Midazolam Reduces Metabolic Viability and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells with Selective Transcriptional Modulation of Wnt and Hedgehog Components: A Preliminary In Vitro Study. Pharmaceuticals (Basel) Korkmaz IF, Elgun T, Aktas C, Eslamkhah S, Sevinc SK, Yurttas AG. PMID: 42797517 [PubMed - in process]

Articles 1 - 20 / 1975996

Page 1 of 98800



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy